Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2025

Mar 4, 2025

29745_dirs_2025-03-04_b6a53734-27d2-4755-af13-ee4f7c4aa9df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-03-03

Reporting Person: LILLY ENDOWMENT INC (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-03 Common Stock S 18828 $922.421 Disposed 96218150 Direct
2025-03-03 Common Stock S 8197 $923.253 Disposed 96209953 Direct
2025-03-03 Common Stock S 7665 $924.529 Disposed 96202288 Direct
2025-03-03 Common Stock S 3691 $925.554 Disposed 96198597 Direct
2025-03-03 Common Stock S 8401 $927.028 Disposed 96190196 Direct
2025-03-03 Common Stock S 21025 $927.81 Disposed 96169171 Direct
2025-03-03 Common Stock S 25984 $928.984 Disposed 96143187 Direct
2025-03-03 Common Stock S 68251 $929.725 Disposed 96074936 Direct
2025-03-03 Common Stock S 25057 $930.74 Disposed 96049879 Direct
2025-03-03 Common Stock S 17393 $931.817 Disposed 96032486 Direct
2025-03-03 Common Stock S 10699 $932.77 Disposed 96021787 Direct
2025-03-03 Common Stock S 3997 $933.735 Disposed 96017790 Direct
2025-03-03 Common Stock S 812 $934.889 Disposed 96016978 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $922.00 to $922.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), and (13) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $923.00 to $923.98, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $924.00 to $924.9905, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.035 to $926.02, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.30 to $927.27, inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.34 to $928.31, inclusive.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.34 to $929.31, inclusive.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.34 to $930.33, inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.34 to $931.33, inclusive.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.37 to $932.36, inclusive.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $932.39 to $933.38, inclusive.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.50 to $934.443, inclusive.

F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.583 to $935.00, inclusive.